Navigation Links
Waging War on Wrinkles: Infini Cosmetic Associates Now Offers Recent FDA Approved Dysport - The Botox Alternative
Date:7/19/2009

Infini Cosmetic Associates in Scottsdale will carry Dysport™ the newly FDA approved wrinkle remover and rival to Botox®. Founder and Chief Surgeon, Dr. William Hall has performed thousands of injections over the last six years and trained many other professionals on Botox® and other injectable dermal fillers. Dr. Hall is very skilled in many of the advanced uses of Botox for: hyperhidrosis (excessive sweating) and nervous tics in the face, neck bands and wrinkles, chin creases and dimpling, lip lines, and lower facial shaping.

Scottsdale, AZ (PRWEB) July 19, 2009 -- Dr. William Hall, Founder and Chief Surgeon at Infini Cosmetic Associates in Scottsdale, announced that Infini Cosmetic Associates will carry Dysport™ the newly FDA approved wrinkle remover and rival to Botox®. Dr. Hall has performed thousands of injections over the last six years and trained many other professionals on Botox® and other injectable dermal fillers. Dr. Hall is very skilled in many of the advanced uses of Botox for: hyperhidrosis (excessive sweating) and nervous tics in the face, neck bands and wrinkles, chin creases and dimpling, lip lines, and lower facial shaping.

The arrival of Dysport™ into the U.S. aesthetics marketplace will no doubt increase competition between the two wrinkle treatments and multiply physician choices and cosmetic options within the same medical practice.

"This is a burgeoning industry and dermal fillers are very popular, so as doctors we are always being introduced to new products that compete with ones we already use - for example I use both Restylane® and Juvederm®," Hall stated. "I have used and trained with Botox® for years and patients love the results, I will offer Dysport™ too, but ultimately, the patients decide after they try both products and see the lasting results," Dr. Hall concluded.

Medicis, a dermal filler leader (known for their popular Restylane® and Perlane® facial fillers) will promote the Dysport™ brand as part of a U.S. sales agreement with the manufacturer, Ipsen. The addition of Dysport™ to their dermal filler arsenal positions Medic as a threatening opponent to the Allergan empire and their line of beauty treatments (Botox® and the Juvederm® - hyaluronic acid gel fillers).

BOTOX® Cosmetic is the solution for many wrinkles, which are actually creases that have been worn into the skin by making the same expression thousands of times. Hall explains - "expression lines" are often called frown lines, crow's feet, or forehead lines and appear due to the contraction of a muscle under the skin in that area. BOTOX® Cosmetic offers a much safer, less invasive option than cutting the muscle and provides more predictable and enhanced results. Some have called this unique therapy "a facelift in a bottle." Now, with Dysport™ there are more products to wage war on age.

Botox and dermal fillers produce long-lasting, amazing results. Visit http://www.infiniskin.com/Wrinkles.html to find out more about wrinkle restoration. For more information about Infini Cosmetic Associates, visit www.infiniskin.com to see photo galleries and the amazing special offers on Botox and dermal fillers. To set up a free consultation, call 480-946-7100.

###

Read the full story at http://www.prweb.com/releases/2009/07/prweb2655704.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. StructuRad Launches MacroLive(TM) with INFINITT and RamSoft at RSNA 2007
2. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
3. Management Consultancy Announces Inaugural Infinitive Championship Series
4. AutoGenomics INFINITI Analyzer Receives Artistic Design Award
5. Infinity Business Systems of Tampa Expands Into Sarasota / Bradenton
6. Thank You, Dunder Mifflin Infinity
7. Infinity Property and Casualty Corporation Declares Quarterly Dividend
8. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
9. ProStor InfiniVault-DICOM Storage System Debuts in Rorke Data Booth at RSNA
10. Shaklee Hits the Road With Its Infinite Possibilities Tour
11. Shaklee Hits the Road with its Infinite Possibilities Tour in New York, NY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider of ... a new solution for Emergency Departments (ED) has been added to their portfolio. ... Department examination rooms, and with a simplified pallet of information available to the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ DiGilio , ... first national #QuackGivesBack campaign which supported local breast cancer organizations during National Breast ... Quack Gives Back initiative, and we’re very pleased with the participation in ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
(Date:12/8/2016)... , ... December 08, 2016 , ... David J. ... global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, ... the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Texas , Dec. 9, 2016  RxWiki Inc., ... apps, and digital marketing strategies of thousands of pharmacies ... it won Austin Inno,s "50 on Fire" ... "We,re pleased to accept the award as ... Loughlin , Chief Executive Officer at RxWiki. "Our platform ...
(Date:12/9/2016)... Dec. 9, 2016  Forge Therapeutics, Inc. today ... Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) to advance ... the treatment of bacterial infections including those caused ... as an attractive antibacterial target for more than ... suitable chemical starting points has hampered its progress. ...
(Date:12/8/2016)... NEW YORK , Dec. 8, 2016 ... ... such as reducing loss of blood during surgeries, lowering the ... surgeries, and decreasing risks of SSIs. The patient warming systems ... and intravascular warming systems.These benefits in turn reduce the stay ...
Breaking Medicine Technology: